202
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Causal relationships between interleukins, interferons and COVID-19 risk: a Mendelian randomization study

, , , &
Pages 2387-2396 | Received 09 Jul 2023, Accepted 23 Aug 2023, Published online: 02 Sep 2023

References

  • Baggiolini M, Clark-Lewis I. 1992. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. Jul 27 307(1):97–101. doi: 10.1016/0014-5793(92)80909-Z. Epub 1992/07/27.
  • Bowden J, Davey Smith G, Burgess S. 2015. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. Apr 44:512–525. doi:10.1093/ije/dyv080. Epub 2015/06/08.
  • Burgess S, Butterworth A, Thompson SG. 2013. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. Nov 37(7):658–665. doi: 10.1002/gepi.21758. Epub 2013/10/12.
  • Busnadiego I, Fernbach S, Pohl MO, Karakus U, Huber M, Trkola A, Stertz S, Hale BG, Palese P. 2020. Antiviral activity of type I, II, and III interferons counterbalances ACE2 inducibility and restricts SARS-CoV-2. mBio. Sep 10 11(5). 10.1128/mBio.01928-20. Epub 2020/09/12.
  • Cesta MC, Zippoli M, Marsiglia C, Gavioli EM, Mantelli F, Allegretti M, Balk RA. 2021. The role of Interleukin-8 in lung inflammation and injury: implications for the management of COVID-19 and hyperinflammatory acute respiratory distress syndrome. Front Pharmacol. 12:808797. doi: 10.3389/fphar.2021.808797. Epub 2022/02/01.
  • Chen X, Hong X, Gao W, Luo S, Cai J, Liu G, Huang Y. 2022. Causal relationship between physical activity, leisure sedentary behaviors and COVID-19 risk: a Mendelian randomization study. J Transl Med. May 13 20(1):216. doi: 10.1186/s12967-022-03407-6. Epub 2022/05/14.
  • Coomes EA, Haghbayan H. 2020. Interleukin-6 in Covid-19: A systematic review and meta-analysis. Rev Med Virol. Nov 30(6):1–9. doi: 10.1002/rmv.2141. Epub 2020/08/28.
  • Fan J, Zhou Y, Meng R, Tang J, Zhu J, Aldrich MC, Cox NJ, Zhu Y, Li Y, Zhou D. 2023. Cross-talks between gut microbiota and tobacco smoking: a two-sample Mendelian randomization study. BMC Med. Apr 28 21(1):163. doi: 10.1186/s12916-023-02863-1. Epub 2023/04/29.
  • Folkersen L, Fauman E, Sabater-Lleal M, Strawbridge RJ, Frånberg M, Sennblad B, Baldassarre D, Veglia F, Humphries SE, Rauramaa R, et al. 2017. Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease. PLoS Genet Apr Epub 2017/04/04. 13(4):e1006706. doi: 10.1371/journal.pgen.1006706.
  • Galbraith MD, Kinning KT, Sullivan KD, Araya P, Smith KP, Granrath RE, Shaw JR, Baxter R, Jordan KR, Russell S, et al. 2022. Specialized interferon action in COVID-19. Proc Natl Acad Sci USA. 119:e2116730119. doi: 10.1073/pnas.2116730119.
  • Gao YD, Agache I, Akdis M, Nadeau K, Klimek L, Jutel M, Akdis CA. 2022. The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19. Int Immunol. Mar 25 34(4):177–188. doi: 10.1093/intimm/dxab107. Epub 2021/11/18.
  • Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, et al. 2018. The MR-Base platform supports systematic causal inference across the human phenome. Elife. May 30 7. 10.7554/eLife.34408. Epub 2018/05/31.
  • Heuberger J, Trimpert J, Vladimirova D, Goosmann C, Lin M, Schmuck R, Mollenkopf HJ, Brinkmann V, Tacke F, Osterrieder N, et al. 2021. Epithelial response to IFN-γ promotes SARS-CoV-2 infection. EMBO Mol Med. Apr 9 13(4):e13191. doi: 10.15252/emmm.202013191. Epub 2021/02/06.
  • Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. Feb 15 395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020/01/28.
  • Hu B, Guo H, Zhou P, Shi ZL. 2021. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol Mar. 19(3):141–154. doi: 10.1038/s41579-020-00459-7. Epub 2020/10/08.
  • Hu B, Huang S, Yin L. 2021. The cytokine storm and COVID-19. J Med Virol. Jan 93(1):250–256. doi: 10.1002/jmv.26232. Epub 2020/06/28.
  • Isath A, Malik AH, Goel A, Gupta R, Shrivastav R, Bandyopadhyay D. 2023. Nationwide analysis of the outcomes and Mortality of Hospitalized COVID-19 patients. Curr Probl Cardiol Feb. 48:101440. doi: 10.1016/j.cpcardiol.2022.101440. Epub 2022/10/11.
  • Iwaszko M, Biały S, Bogunia-Kubik K. 2021. Significance of Interleukin (IL)-4 and IL-13 in inflammatory Arthritis. Cells. Nov 3 10(11):3000. doi: 10.3390/cells10113000. Epub 2021/11/28.
  • Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, El Jammal T, Walzer T, François B, Sève P. 2020. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. Jul 19(7):102567. doi: 10.1016/j.autrev.2020.102567. Epub 2020/05/08.
  • Kandikattu HK, Upparahalli Venkateshaiah S, Mishra A. 2019. Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases. Cytokine Growth Factor Rev Jun. 47:83–98. doi: 10.1016/j.cytogfr.2019.05.003. Epub 2019/05/28.
  • Kang S, Kishimoto T. 2021. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Experimental & Molecular Medicine. Jul 53(7):1116–1123. doi: 10.1038/s12276-021-00649-0. Epub 2021/07/14.
  • Kang S, Tanaka T, Inoue H, Ono C, Hashimoto S, Kioi Y, Matsumoto H, Matsuura H, Matsubara T, Shimizu K, et al. 2020. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proc Natl Acad Sci U S A. Sep 8 117(36):22351–22356. doi: 10.1073/pnas.2010229117. Epub 2020/08/23.
  • Kishimoto T. 2010. IL-6: from its discovery to clinical applications. Int Immunol May. 22:347–352. doi: 10.1093/intimm/dxq030. Epub 2010/04/23.
  • Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. 2008. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. Apr 15 27(8):1133–1163. doi: 10.1002/sim.3034. Epub 2007/09/22.
  • Li J, Rong L, Cui R, Feng J, Jin Y, Chen X, Xu R. 2021. Dynamic changes in serum IL-6, IL-8, and IL-10 predict the outcome of ICU patients with severe COVID-19. Ann Palliat Med Apr. 10(4):3706–3714. doi: 10.21037/apm-20-2134. Epub 2021/02/23.
  • Li J, Tian A, Zhu H, Chen L, Wen J, Liu W, Chen P. 2022. Mendelian randomization analysis Reveals no causal Relationship between Nonalcoholic Fatty Liver disease and severe COVID-19. Clin Gastroenterol Hepatol. Jul 20:1553–1560.e1578. doi:10.1016/j.cgh.2022.01.045. Epub 2022/02/07.
  • Liu S, Zhi Y, Ying S. 2020. COVID-19 and Asthma: Reflection During the pandemic. Clin Rev Allergy Immunol. Aug 59(1):78–88. doi: 10.1007/s12016-020-08797-3. Epub 2020/05/30.
  • Li P, Wang H, Guo L, Gou X, Chen G, Lin D, Fan D, Guo X, Liu Z. 2022. Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study. BMC Med. Nov 15 20(1):443. doi: 10.1186/s12916-022-02657-x. Epub 2022/11/17.
  • Li SF, Zhao FR, Shao JJ, Xie YL, Chang HY, Zhang YG. 2017. Interferon-omega: Current status in clinical applications. Int Immunopharmacol. Nov 52:253–260. doi:10.1016/j.intimp.2017.08.028. Epub 2017/09/29.
  • Ma A, Zhang L, Ye X, Chen J, Yu J, Zhuang L, Weng C, Petersen F, Wang Z, Yu X. 2021. High levels of Circulating IL-8 and Soluble IL-2R are associated with Prolonged Illness in patients with severe COVID-19. Front Immunol. 12:626235. doi: 10.3389/fimmu.2021.626235. Epub 2021/02/16.
  • Murdaca G, Greco M, Tonacci A, Negrini S, Borro M, Puppo F, Gangemi S. 2019. IL-33/IL-31 Axis in immune-Mediated and Allergic diseases. Int J Mol Sci. Nov 22 20(23):5856. doi: 10.3390/ijms20235856. Epub 2019/11/27.
  • Nagant C, Ponthieux F, Smet J, Dauby N, Doyen V, Besse-Hammer T, De Bels D, Maillart E, Corazza F. 2020. A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer. Int J Infect Dis. Dec 101:342–345. doi:10.1016/j.ijid.2020.10.003. Epub 2020/10/12.
  • Neurath MF. 2020. IL-36 in chronic inflammation and cancer. Cytokine Growth Factor Rev. Sep 55:70–79. doi:10.1016/j.cytogfr.2020.06.006. Epub 2020/06/17.
  • Peng H, Wu X, Xiong S, Li C, Zhong R, He J, Liang W. 2022. Gout and susceptibility and severity of COVID-19: A bidirectional Mendelian randomization analysis. J Infect. Sep 85(3):e59–e61. doi: 10.1016/j.jinf.2022.05.042. Epub 2022/06/21.
  • Ponsford MJ, Gkatzionis A, Walker VM, Grant AJ, Wootton RE, Moore LSP, Fatumo S, Mason AM, Zuber V, Willer C, et al. 2020. Cardiometabolic Traits, Sepsis, and severe COVID-19: A Mendelian randomization Investigation. Circulation. Nov 3 142(18):1791–1793. doi: 10.1161/CIRCULATIONAHA.120.050753. Epub 2020/09/24.
  • Qin XJ, Shi HZ, Huang ZX, Kang LF, Mo WN, Wu C. 2005. Interleukin-16 in tuberculous and malignant pleural effusions. Eur Respir J. Apr 25:605–611. doi:10.1183/09031936.05.00090804. Epub 2005/04/02.
  • Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W, et al. 2020. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. Jul 28 71(15):762–768. doi: 10.1093/cid/ciaa248. Epub 2020/03/13.
  • Samuel CE. 2001. Antiviral actions of interferons. Clin Microbiol Rev. Nov 14(4):778–809. doi: 10.1128/CMR.14.4.778-809.2001. table of contents. Epub 2001/10/05.
  • Sekula P, Del Greco MF, Pattaro C, Köttgen A. 2016. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. Nov 27(11):3253–3265. doi: 10.1681/ASN.2016010098. Epub 2016/11/02.
  • Smith GD, Ebrahim S. 2003. Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. Feb 32:1–22. doi:10.1093/ije/dyg070. Epub 2003/04/12.
  • Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, Horick NK, Healy BC, Shah R, Bensaci AM, et al. 2020. Efficacy of tocilizumab in patients hospitalized with Covid-19. N Engl J Med. Dec 10 383(24):2333–2344. doi: 10.1056/NEJMoa2028836. Epub 2020/10/22.
  • Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, Burgess S, Jiang T, Paige E, Surendran P, et al. 2018. Genomic atlas of the human plasma proteome. Nature. Jun 558(7708):73–79. 10.1038/s41586-018-0175-2. Epub 2018/06/08.
  • Su Z, Tao X. 2021. Current understanding of IL-37 in human health and disease. Front Immunol. 12:696605. doi: 10.3389/fimmu.2021.696605. Epub 2021/07/13.
  • Takatsu K, Nakajima H. 2008. IL-5 and eosinophilia. Curr Opin Immunol. Jun 20:288–294. doi:10.1016/j.coi.2008.04.001. Epub 2008/05/31.
  • Tanaka T, Narazaki M, Kishimoto T. 2016. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy. Jul 8(8):959–970. doi: 10.2217/imt-2016-0020. Epub 2016/07/07.
  • Tokajian S, Merhi G, Al Khoury C, Nemer G. 2021. Interleukin-37: a link between COVID-19, diabetes, and the black fungus. Front Microbiol. 12:788741. doi: 10.3389/fmicb.2021.788741. Epub 2022/02/01.
  • Varricchi G, Poto R, Marone G, Schroeder JT. 2021. IL-3 in the development and function of basophils. Semin Immunol Apr. 54:101510. doi: 10.1016/j.smim.2021.101510. Epub 2021/11/11.
  • Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. 2020. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama. Mar 17323:1061–1069. doi:10.1001/jama.2020.1585. Epub 2020/02/08.
  • Wang C, Yu R, Zhang S, Zhao Y, Qi C, Zhu Z, Chen X, Bi J, Xu P, Cheng L, et al. 2022. Genome-wide Mendelian randomization and single-cell RNA sequencing analyses identify the causal effects of COVID-19 on 41 cytokines. Brief Funct Genomics. Nov 17 21(6):423–432. doi: 10.1093/bfgp/elac033. Epub 2022/10/26.
  • Xie G, Ding F, Han L, Yin D, Lu H, Zhang M. 2021. The role of peripheral blood eosinophil counts in COVID-19 patients. Allergy Feb. 76(2):471–482. doi: 10.1111/all.14465. Epub 2020/06/21.
  • Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. 2020. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 8:475–481. doi:10.1016/S2213-2600(20)30079-5. Epub 2020/02/28.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.